Mahiru Kawano

1.5k total citations
39 papers, 1.1k citations indexed

About

Mahiru Kawano is a scholar working on Oncology, Immunology and Reproductive Medicine. According to data from OpenAlex, Mahiru Kawano has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Immunology and 16 papers in Reproductive Medicine. Recurrent topics in Mahiru Kawano's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Inflammatory Biomarkers in Disease Prognosis (10 papers). Mahiru Kawano is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Inflammatory Biomarkers in Disease Prognosis (10 papers). Mahiru Kawano collaborates with scholars based in Japan, United States and China. Mahiru Kawano's co-authors include Seiji Mabuchi, Tadashi Kimura, Yuri Matsumoto, Kenjiro Sawada, Hiromasa Kuroda, Tomoyuki Sasano, Shigekazu Nagata, Kae Hashimoto, Ryoko Takahashi and Katsumi Kozasa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Mahiru Kawano

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mahiru Kawano Japan	21	502	497	321	242	201	39	1.1k
Tomoyuki Sasano Japan	21	558 1.1×	473 1.0×	249 0.8×	268 1.1×	141 0.7×	44	1.1k
Yuri Matsumoto Japan	22	675 1.3×	494 1.0×	324 1.0×	369 1.5×	248 1.2×	53	1.3k
Kirsten Kübler Germany	15	339 0.7×	276 0.6×	344 1.1×	82 0.3×	243 1.2×	27	924
Mark E. Borowsky United States	13	329 0.7×	237 0.5×	339 1.1×	165 0.7×	103 0.5×	24	896
Mana Taki Japan	10	546 1.1×	484 1.0×	275 0.9×	97 0.4×	178 0.9×	46	1.0k
Thaïs Baert Belgium	16	400 0.8×	260 0.5×	149 0.5×	219 0.9×	102 0.5×	47	955
Ayumi Hongo Japan	17	370 0.7×	180 0.4×	508 1.6×	146 0.6×	177 0.9×	31	944
Els Van Nieuwenhuysen Belgium	20	559 1.1×	180 0.4×	372 1.2×	227 0.9×	325 1.6×	99	1.3k
Tilmann Lantzsch Germany	14	294 0.6×	119 0.2×	237 0.7×	144 0.6×	209 1.0×	26	819
Thomas T. Tapmeier United Kingdom	15	178 0.4×	460 0.9×	220 0.7×	218 0.9×	89 0.4×	23	873

Countries citing papers authored by Mahiru Kawano

Since Specialization

Citations

This map shows the geographic impact of Mahiru Kawano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahiru Kawano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahiru Kawano more than expected).

Fields of papers citing papers by Mahiru Kawano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahiru Kawano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahiru Kawano. The network helps show where Mahiru Kawano may publish in the future.

Co-authorship network of co-authors of Mahiru Kawano

This figure shows the co-authorship network connecting the top 25 collaborators of Mahiru Kawano. A scholar is included among the top collaborators of Mahiru Kawano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahiru Kawano. Mahiru Kawano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kinose, Yasuto, Koji Nakamura, Aska Toda, et al.. (2025). PI3K/mTOR Dual Inhibitor GSK458 and Arsenic Trioxide Exert Synergistic Antitumor Effects against Ovarian Clear-Cell Carcinoma. Molecular Cancer Therapeutics. 24(4). 563–575. 1 indexed citations

Kawano, Mahiru, et al.. (2025). Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency. Biology of Reproduction. 112(5). 906–915.

Yamamoto, Gaku, Mahiru Kawano, Aska Toda, et al.. (2024). Abstract 5329: Ovarian cancer predisposes neutrophils to form neutrophil extracellular traps(NETs). Cancer Research. 84(6_Supplement). 5329–5329. 3 indexed citations

Komura, Naoko, Seiji Mabuchi, Kotaro Shimura, et al.. (2020). Significance of Pretreatment C-Reactive Protein, Albumin, and C-Reactive Protein to Albumin Ratio in Predicting Poor Prognosis in Epithelial Ovarian Cancer Patients. Nutrition and Cancer. 73(8). 1357–1364. 21 indexed citations

Kobayashi, Masaki, Kenjiro Sawada, Mayuko Miyamoto, et al.. (2020). Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer. Biochemical and Biophysical Research Communications. 527(1). 153–161. 90 indexed citations

Mabuchi, Seiji, Naoko Komura, Tomoyuki Sasano, et al.. (2020). Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies. Nature Communications. 11(1). 1364–1364. 22 indexed citations

Komura, Naoko, Seiji Mabuchi, Eriko Yokoi, et al.. (2019). Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer. International Journal of Gynecological Cancer. 29(6). 1057–1063. 8 indexed citations

Komura, Naoko, Seiji Mabuchi, Eriko Yokoi, et al.. (2019). Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer. Oncotarget. 10(38). 3605–3613. 24 indexed citations

Sasano, Tomoyuki, Seiji Mabuchi, Katsumi Kozasa, et al.. (2018). The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations. Clinical Cancer Research. 24(16). 4018–4029. 40 indexed citations

10.

Yokoi, Eriko, Seiji Mabuchi, Kotaro Shimura, et al.. (2018). Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer. Investigational New Drugs. 37(5). 818–827. 20 indexed citations

11.

Kawano, Mahiru & Shigekazu Nagata. (2018). Efferocytosis and autoimmune disease. International Immunology. 30(12). 551–558. 61 indexed citations

12.

Kuroda, Hiromasa, Seiji Mabuchi, Katsumi Kozasa, et al.. (2017). PM01183 Inhibits Myeloid-Derived Suppressor Cells In Vitro and In Vivo. Immunotherapy. 9(10). 805–817. 16 indexed citations

13.

Takahashi, Ryoko, Seiji Mabuchi, Mahiru Kawano, et al.. (2015). Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study. Gynecologic Oncology. 137(1). 112–118. 40 indexed citations

14.

Kawano, Mahiru, Seiji Mabuchi, Yuri Matsumoto, et al.. (2015). Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy. International Journal of Gynecological Cancer. 25(9). 1656–1662. 12 indexed citations

15.

Matsuo, Koji, Seiji Mabuchi, Mika Okazawa, et al.. (2015). Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors. Journal of Gynecologic Oncology. 26(1). 3–3. 22 indexed citations

16.

Kawano, Mahiru, Seiji Mabuchi, Yuri Matsumoto, et al.. (2015). The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. Scientific Reports. 5(1). 18217–18217. 124 indexed citations

17.

Kawano, Mahiru, Seiji Mabuchi, Takeshi Hisamatsu, et al.. (2014). Combination Treatment With Trabectedin and Irinotecan or Topotecan Has Synergistic Effects Against Ovarian Clear Cell Carcinoma Cells. International Journal of Gynecological Cancer. 24(5). 829–837. 11 indexed citations

18.

Hisamatsu, Takeshi, Seiji Mabuchi, Yuri Matsumoto, et al.. (2013). Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 12(7). 1367–1377. 37 indexed citations

19.

Mabuchi, Seiji, Mika Okazawa, Koji Matsuo, et al.. (2012). Impact of histological subtype on survival of patients with surgically-treated stage IA2–IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma. Gynecologic Oncology. 127(1). 114–120. 77 indexed citations

20.

Mabuchi, Seiji, Yuri Matsumoto, Toshimitsu Hamasaki, et al.. (2012). Elevated White Blood Cell Count at the Time of Recurrence Diagnosis Is an Indicator of Short Survival in Patients With Recurrent Cervical Cancer. International Journal of Gynecological Cancer. 22(9). 1545–1551. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact